Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REDUNING injection versus oseltamivir for influenza high fever
ChiCTR-IPR-14005665Phase 3Recruiting
- Sponsor
- Tianjin University of Traditional Chinese Medicine
- Start
- Dec 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Reduning in influenza (2 arms), sponsored by Tianjin University of Traditional Chinese Medicine. Primary endpoint: Time to temperature normalization. Started Dec 2014; status: recruiting.
02
Drugs
Reduning
03
Conditions
influenza
Beyond the preview
Go deeper on ChiCTR-IPR-14005665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-14005665.